Efficacy of continuous zanubrutinib monotherapy versus fixed-duration acalabrutinib plus venetoclax or venetoclax plus obinutuzumab in treatment-naïve chronic lymphocytic leukemia: a network meta-analysis

Answers are grounded in this paper and cite their sources.

• What is the pooled effect, and how consistent were the studies?
• Which studies were included?
• How strong is this evidence, and where could bias creep in?